Details of the Drug Formulations

General Information of Drug (ID: DMI5OXG)

Drug Name
Latanoprost Drug Info
Synonyms
Catioprost; Xalatan; Latanoprost free acid; L1167_SIGMA; PhXA41; XA41; AR-202; Nova-21027; PHXA-41; XA-41; Xalatan (TN); Latanoprost (JAN/USAN/INN); PhXA34 [as 15(R,S)-isomer]; Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprost-5-en-1-oate; Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate; Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate; Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate; Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate
Indication
Disease Entry ICD 11 Status REF
Ocular hypertension 9C61.01 Approved [1]
Open-angle glaucoma 9C61 Approved [2]
OPTN-related open angle glaucoma Approved [1]
Glaucoma/ocular hypertension 9C61 Phase 2 [3]
Ocular disease 1F00.1Z Investigative [4]
Therapeutic Class
Antihypertensive Agents
Cross-matching ID
PubChem CID
5311221
ChEBI ID
CHEBI:6384
CAS Number
130209-82-4
TTD ID
D0C6NM
VARIDT ID
DR00168
ACDINA ID
D01199

Full List of Drug Formulations Containing This Drug

Latanoprost 0.005% solution
Company Formulation ID FDA Description
Sun Pharmaceutical Industries F23801 Castor Oil; Sodium Borate; Boric Acid; Propylene Glycol; Edetate Disodium; Polyoxyl 15 Hydroxystearate; Sodium Hydroxide; Hydrochloric Acid; Water
Greenstone ; Nucare Pharmaceuticals F24273 Sodium Chloride; Sodium Dihydrogen Phosphate Monohydrate; Disodium Hydrogen Phosphate Anhydrous; Water
------------------------------------------------------------------------------------

References

1 Latanoprost FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1961).
3 Clinical pipeline report, company report or official report of Mati therapeutics.
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 344).